Dashboard
Manage Tickers

IVVDInvivyd, Inc.

Nasdaq invivyd.com


$ 1.70 $ -0.06 (-3.43 %)    

Friday, 07-Jun-2024 15:59:52 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 462.76 $ -0.41 (-0.09 %)
DIA $ 388.38 $ -0.84 (-0.22 %)
SPY $ 533.54 $ -0.65 (-0.12 %)
TLT $ 91.51 $ -1.71 (-1.83 %)
GLD $ 211.60 $ -7.83 (-3.57 %)
$ 1.69
$ 1.77
$ 1.69 x 351
$ 1.70 x 400
$ 1.69 - $ 1.80
$ 0.98 - $ 5.20
223,246
na
195.39M
$ 1.09
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-28-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-23-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-13-2022 03-31-2022 10-Q
10 03-31-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 09-20-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

invivyd-appoints-timothy-lee-as-chief-commercial-officer-lees-appointment-follows-companys-decision-to-eliminate-chief-operating-officer-role-to-reallocate-resources-to-support-launch-of-pemgarda
Invivyd Appoints Timothy Lee As Chief Comm...
05/31/2024 11:19:44

Mr. Lee's appointment follows the decision by the Board of Directors to eliminate the Chief Operating Officer role as part ...

invivyd-discloses-general-alignment-with-us-fda-on-repeatable-expedient-emergency-use-authorization-pathway-for-prevention-and-treatment-of-symptomatic-covid-19-based-on-compact-clinical-programs-to-establish-safety-and-immunobridging
Invivyd Discloses General Alignment With U...
05/31/2024 11:14:33

Newly outlined pathway provides a practical, expedient, repeatable immunobridging approach to potential emergency use authori...

hc-wainwright--co-reiterates-buy-on-invivyd-maintains-15-price-target
HC Wainwright & Co. Reiterates Buy on Invi...
05/24/2024 16:50:31

HC Wainwright & Co. analyst Patrick Trucchio reiterates Invivyd (NASDAQ:IVVD) with a Buy and maintains $15 price target.

hc-wainwright--co-reiterates-buy-on-invivyd-maintains-15-price-target
HC Wainwright & Co. Reiterates Buy on Invi...
05/14/2024 16:35:16

HC Wainwright & Co. analyst Patrick Trucchio reiterates Invivyd (NASDAQ:IVVD) with a Buy and maintains $15 price target.

invivyd-to-pursue-rapid-immunobridging-pathway-to-potential-eua-for-treatment-of-covid-19-in-moderately-to-severely-immunocompromised-people-based-on-us-fda-feedback
Invivyd To Pursue Rapid Immunobridging Pat...
05/07/2024 11:39:17

invivyd-receives-healthcare-common-procedure-coding-system-reimbursement-codes-from-us-centers-for-medicare--medicaid-services-covering-pemgarda
Invivyd Receives Healthcare Common Procedu...
04/15/2024 11:34:05

invivyd-reveals-ceo-transition-appoints-jeremy-gowler-as-interim-ceo-effective-immediately-to-succeed-dave-hering
Invivyd Reveals CEO Transition; Appoints J...
04/12/2024 11:33:19

invivyd-shares-are-trading-higher-after-the-company-announced-pemgarda-is-available-for-purchase-in-the-us-and-said-it-sees-initial-fy24-pemgarda-net-product-revenue-guidance-in-the-range-of-150-million-to-200-million
Invivyd shares are trading higher after th...
04/05/2024 12:19:57

guggenheim-upgrades-invivyd-to-buy-announces-9-price-target
Guggenheim Upgrades Invivyd to Buy, Announ...
04/05/2024 12:13:55

Guggenheim analyst Evan Wang upgrades Invivyd (NASDAQ:IVVD) from Neutral to Buy and announces $9 price target.

kura-sushi-posts-upbeat-sales-joins-caribou-biosciences-krispy-kreme-and-other-big-stocks-moving-higher-in-fridays-pre-market-session
Kura Sushi Posts Upbeat Sales, Joins Carib...
04/05/2024 12:01:39

U.S. stock futures were higher this morning, with the Dow futures gaining by around 100 points on Friday.

invivyd-sees-fy24-initial-pemgarda-net-product-revenue-150m-200m
Invivyd Sees FY24 Initial PEMGARDA Net Pro...
04/04/2024 20:05:32

invivyds-pemgarda-commercially-available-in-us-for-pre-exposure-prophylaxis-of-covid-19-in-certain-adults-and-adolescents-with-moderate-to-severe-immune-compromise
Invivyd's PEMGARDA Commercially Available ...
04/04/2024 20:03:21

invivyd-q4-earnings-insights
Invivyd: Q4 Earnings Insights
03/28/2024 13:25:07

invivyd-fy23-eps-181-vs-223-yoy
Invivyd FY23 EPS $(1.81) Vs $(2.23) YoY
03/28/2024 11:20:39

why-westport-fuel-systems-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Westport Fuel Systems Shares Are Tradi...
03/26/2024 17:45:27

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected ...

tesla-krispy-kreme-mccormick-and-other-big-stocks-moving-higher-on-tuesday
Tesla, Krispy Kreme, McCormick And Other B...
03/26/2024 14:36:08

U.S. stocks were higher, with the Dow Jones index gaining around 50 points on Tuesday.

why-stoke-therapeutics-shares-are-trading-higher-by-around-70-here-are-20-stocks-moving-premarket
Why Stoke Therapeutics Shares Are Trading ...
03/26/2024 12:00:29

Shares of Stoke Therapeutics, Inc. (NASDAQ: STOK) rose sharply in today’s pre-market trading after the company announced Phase...

morgan-stanley-upgrades-invivyd-to-overweight-raises-price-target-to-10
Morgan Stanley Upgrades Invivyd to Overwei...
03/26/2024 09:28:48

Morgan Stanley analyst Maxwell Skor upgrades Invivyd (NASDAQ:IVVD) from Equal-Weight to Overweight and raises the price targ...

why-landos-biopharma-shares-are-trading-higher-by-over-170-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Landos Biopharma Shares Are Trading Hi...
03/25/2024 18:44:08

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
03/25/2024 17:30:58

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION